Pacira BioSciences (PCRX) Operating Income (2010 - 2026)
Pacira BioSciences (PCRX) reported Operating Income of $4.27 million for Q2 2026, down 49.8% from $8.5 million a year earlier and down 38.2% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Pacira BioSciences' Operating Income came in at $19.87 million; for FY2025, it came in at $19.19 million.
- Operating Income has a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
- By year, Operating Income came in at -$73.37 million in FY2024, $87.68 million in FY2023 (+46.1%), $60.02 million in FY2022 (-33.3%) and $89.92 million in FY2021 (+94.0%).
- Five-year quarterly Operating Income spans a low of -$139.53 million in Q3 2024 and a high of $39.88 million in Q2 2023.
- Year over year, Operating Income gained in 1 of the last six quarters, with an average decline of 12.3%.
- The high point for year-over-year Operating Income in five years was Q1 2026 (growth of 246.8%); the low point was Q4 2025 (a decline of 90.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.9 million (Q1 2026), $2.34 million (Q4 2025) and $6.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Pacira BioSciences | 1.46 Bn | 468.61 Mn | 139.42 Mn | 22.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 22.27 Mn |
| Jun 30, 2026 | 4.27 Mn |
| Mar 31, 2026 | 6.90 Mn |
| Dec 31, 2025 | 2.34 Mn |
| Sep 30, 2025 | 6.36 Mn |
| Jun 30, 2025 | 8.50 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 24.70 Mn |
| Sep 30, 2024 | -139.53 Mn |
| Jun 30, 2024 | 28.24 Mn |
| Mar 31, 2024 | 13.21 Mn |
| Dec 31, 2023 | 33.17 Mn |
| Sep 30, 2023 | 17.72 Mn |
| Jun 30, 2023 | 39.88 Mn |
| Mar 31, 2023 | -3.09 Mn |
| Dec 31, 2022 | -9.89 Mn |
| Sep 30, 2022 | 21.29 Mn |
| Jun 30, 2022 | 31.24 Mn |
| Mar 31, 2022 | 17.39 Mn |
| Dec 31, 2021 | 4.21 Mn |
API Access
Pacira BioSciences Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();